Please enable Javascript to use all features and improve your user experience.
EHC 2022
Programme
Posters
People
Search
EN
All people
Brett Dabruzzo
Sort by Type
Date
Further involvements
09 Dec
15:45
–
15:50
3 Min.
2 Min.
ePoster
P141
Safety and tolerability of atogepant: a post hoc analysis of pooled data from four clinical trials
Migraine
09 Dec
15:45
–
15:50
3 Min.
2 Min.
ePoster
P105
Sustained Response to Atogepant in Individuals with Episodic Migraine: Post Hoc Analyses of 12- and 52-Week Phase 3 Trials
Migraine
09 Dec
15:50
–
15:55
3 Min.
2 Min.
ePoster
P124
Characterizing gaps in preventive treatment of migraine: global results from the CaMEO-International study
Migraine
09 Dec
15:50
–
15:55
3 Min.
2 Min.
ePoster
P106
Post-hoc Analysis Evaluating Safety of Atogepant in ADVANCE & Open-Label Extension Participants with Cardiovascular Risk Factors
Migraine
09 Dec
16:10
–
16:15
3 Min.
2 Min.
ePoster
P110
Subsequent Response to Atogepant in Individuals with Episodic Migraine after an Initial Inadequate Response: Post Hoc Analysis of a 12-week Phase 3 Trial
Migraine
09 Dec
16:55
–
17:00
3 Min.
2 Min.
ePoster
P120
Monthly Migraine Days, Acute Medication Use Days, and Migraine-Specific Quality of Life in Responders to Atogepant: A Post Hoc Analysis
Migraine
v1.21.0
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy